These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 16567304)
21. Canadian implantable defibrillator study: what does it mean after the antiarrhythmics versus implantable defibrillators trial? Subramanian VA; Patel NU Curr Cardiol Rep; 2000 Nov; 2(6):489-91. PubMed ID: 11060575 [No Abstract] [Full Text] [Related]
22. Electrocardiographic and echocardiographic features of a disconnected right ventricle. Affolter JT; Broadhurst P; Bourke JP Heart; 2005 May; 91(5):e39. PubMed ID: 15831624 [No Abstract] [Full Text] [Related]
23. Fibrillation and defibrillation of the heart. Bossaert LL Br J Anaesth; 1997 Aug; 79(2):203-13. PubMed ID: 9349131 [No Abstract] [Full Text] [Related]
25. Dual defibrillation for refractory ventricular fibrillation in a patient with a left ventricular assist device. Fender E; Tripuraneni A; Henrikson CA J Heart Lung Transplant; 2013 Nov; 32(11):1144-5. PubMed ID: 23953919 [No Abstract] [Full Text] [Related]
26. Right ventricular outflow tract implantation of an active fixation defibrillation lead through a persistent left superior vena cava. Siliste C; Vinereanu D; Margulescu AD; Cinteza M Europace; 2008 Dec; 10(12):1454-5. PubMed ID: 18948364 [TBL] [Abstract][Full Text] [Related]
28. Antitachycardia pacing therapy for the successful treatment of lead fracture. Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719 [No Abstract] [Full Text] [Related]
29. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ; Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390 [TBL] [Abstract][Full Text] [Related]
30. The impact of acute myocardial ischemia on the ventricular defibrillation threshold during chronic oral azimilide therapy. Chevalier P; Dubieff AD; Piqueras E; Pineau J; Rivard L; Morel E; Bui-Xan B; Timour Q J Cardiovasc Pharmacol; 2007 Dec; 50(6):629-32. PubMed ID: 18091578 [TBL] [Abstract][Full Text] [Related]
31. Successful reduction of a high defibrillation threshold by a combined implantation of a subcutaneous array and azygos vein lead. Yamada T; Robertson PG; McElderry HT; Doppalapudi H; Plumb VJ; Kay GN Pacing Clin Electrophysiol; 2012 Jun; 35(6):e173-6. PubMed ID: 22360586 [TBL] [Abstract][Full Text] [Related]
33. Electrode system for permanent implantable defibrillators: transvenous catheter and subcutaneous plate electrodes. Ewy GA; Thomas E; Taren D Med Instrum; 1978; 12(5):296-300. PubMed ID: 703654 [TBL] [Abstract][Full Text] [Related]